JB Chemicals & Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2026: 14.87%

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has an Asset Resilience Ratio of 14.87% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs7.39 Billion

≈ $79.91 Million USD Cash + Short-term Investments

Total Assets

Rs49.69 Billion

≈ $537.34 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2026)

This chart shows how JB Chemicals & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see JB Chemicals & Pharmaceuticals Limited assets under control.

Liquid Assets Composition Over Time

This chart breaks down JB Chemicals & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs7.39 Billion	14.87%
Total Liquid Assets	Rs7.39 Billion	14.87%

Asset Resilience Insights

Moderate Liquidity: JB Chemicals & Pharmaceuticals Limited has 14.87% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

JB Chemicals & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare JB Chemicals & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for JB Chemicals & Pharmaceuticals Limited (2006–2026)

The table below shows the annual Asset Resilience Ratio data for JB Chemicals & Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	14.87%	Rs7.39 Billion ≈ $79.91 Million	Rs49.69 Billion ≈ $537.34 Million	+6.19pp
2025-03-31	8.68%	Rs3.71 Billion ≈ $40.12 Million	Rs42.74 Billion ≈ $462.19 Million	-1.21pp
2024-03-31	9.89%	Rs3.95 Billion ≈ $42.71 Million	Rs39.94 Billion ≈ $431.95 Million	+3.05pp
2023-03-31	6.83%	Rs2.43 Billion ≈ $26.26 Million	Rs35.54 Billion ≈ $384.34 Million	+6.76pp
2022-03-31	0.07%	Rs19.26 Million ≈ $208.31K	Rs26.07 Billion ≈ $281.98 Million	-29.79pp
2021-03-31	29.86%	Rs6.68 Billion ≈ $72.28 Million	Rs22.38 Billion ≈ $242.04 Million	+9.86pp
2020-03-31	20.01%	Rs3.63 Billion ≈ $39.24 Million	Rs18.14 Billion ≈ $196.13 Million	-0.98pp
2019-03-31	20.99%	Rs3.76 Billion ≈ $40.65 Million	Rs17.91 Billion ≈ $193.69 Million	-1.10pp
2018-03-31	22.09%	Rs3.90 Billion ≈ $42.16 Million	Rs17.65 Billion ≈ $190.87 Million	+8.65pp
2017-03-31	13.44%	Rs2.25 Billion ≈ $24.33 Million	Rs16.74 Billion ≈ $181.04 Million	+0.90pp
2016-03-31	12.54%	Rs1.95 Billion ≈ $21.12 Million	Rs15.57 Billion ≈ $168.43 Million	-24.84pp
2015-03-31	37.38%	Rs5.56 Billion ≈ $60.12 Million	Rs14.87 Billion ≈ $160.84 Million	+0.58pp
2014-03-31	36.81%	Rs4.97 Billion ≈ $53.78 Million	Rs13.51 Billion ≈ $146.11 Million	+6.20pp
2013-03-31	30.61%	Rs3.98 Billion ≈ $43.04 Million	Rs13.00 Billion ≈ $140.61 Million	+5.65pp
2012-03-31	24.96%	Rs2.99 Billion ≈ $32.33 Million	Rs11.98 Billion ≈ $129.54 Million	+18.14pp
2011-03-31	6.82%	Rs681.15 Million ≈ $7.37 Million	Rs9.99 Billion ≈ $108.08 Million	-0.32pp
2010-03-31	7.13%	Rs596.82 Million ≈ $6.45 Million	Rs8.37 Billion ≈ $90.51 Million	-0.64pp
2009-03-31	7.77%	Rs579.99 Million ≈ $6.27 Million	Rs7.46 Billion ≈ $80.71 Million	-0.34pp
2008-03-31	8.11%	Rs601.32 Million ≈ $6.50 Million	Rs7.41 Billion ≈ $80.17 Million	+2.87pp
2007-03-31	5.24%	Rs373.14 Million ≈ $4.04 Million	Rs7.12 Billion ≈ $77.03 Million	-0.01pp
2006-03-31	5.25%	Rs265.04 Million ≈ $2.87 Million	Rs5.05 Billion ≈ $54.64 Million	--

pp = percentage points

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$4.18 Billion

Rs386.77 Billion INR

Market Cap Rank

#4017 Global

#177 in India

Share Price

Rs2408.90

Change (1 day)

-3.87%

52-Week Range

Rs1656.70 - Rs2506.00

All Time High

Rs2506.00